文献速递肺血管病与心包/心肌炎

肺动脉高压右心室重构模式预测治疗反应

Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response.
PubMed 文献 · Heart · 2022-08-11

该研究基于ASPIRE注册队列,纳入505例肺动脉高压患者,用心脏磁共振在基线和随访时评估右心室适应模式。按右心室收缩末期容积指数和心室质量指数分为四组,高容积低质量组预后显著差于低容积低质量组,且仅17.4%在高容积低质量组患者经治疗转为低容积低质量组。

要点

  • 基于CMR的右心室适应模式可用于肺动脉高压患者风险分层。
  • 高容积低质量组患者治疗失败风险高,预后差于低容积低质量组。
  • 治疗随访中高容积低质量组仅少数转为低容积低质量组。

核心结论

  • 基于CMR评估的右心室适应模式在肺动脉高压患者中具有预后价值。
  • 适应不良重构(高容积低质量)患者治疗失败风险高。

研究设计与样本

  • 研究为注册队列分析,纳入ASPIRE注册中排除先天性心脏病后的连续肺动脉高压患者505例。
  • 用年龄和性别校正的右心室收缩末期容积指数与心室质量指数将患者分为四组。
  • 采用单因素方差分析和Kaplan-Meier图评估各组预后价值,并研究组间转换。

主要发现

  • 505例患者中239例(47.3%)在随访期间死亡,随访中位4.85年(IQR 4.05)。
  • 患者平均年龄59±16岁,男性161例(32.7%)。
  • 低容积低质量组与提示预后改善的CMR和右心导管指标相关。
  • 124例患者进行了随访CMR,中位1.11年(IQR 0.78)。
  • 基线和随访时,高容积低质量组预后均差于低容积低质量组(p<0.001)。

临床怎么用

  • 可利用CMR评估的右心室容积与质量模式对肺动脉高压患者进行风险分层。
  • 对高容积低质量(适应不良重构)患者应警惕治疗失败风险,加强随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine the prognostic value of patterns of right ventricular adaptation in patients with pulmonary arterial hypertension (PAH), assessed using cardiac magnetic resonance (CMR) imaging at baseline and follow-up. METHODS: Patients attending the Sheffield Pulmonary Vascular Disease Unit with suspected pulmonary hypertension were recruited into the ASPIRE (Assessing the Spectrum of Pulmonary hypertension Identified at a REferral Centre) Registry. With exclusion of congenital heart disease, consecutive patients with PAH were followed up until the date of census or death. Right ventricular end-systolic volume index adjusted for age and sex and ventricular mass index were used to categorise patients into four different volume/mass groups: low-volume-low-mass, low-volume-high-mass, high-volume-low-mass and high-volume-high-mass. The prognostic value of the groups was assessed with one-way analysis of variance and Kaplan-Meier plots. Transition of the groups was studied. RESULTS: A total of 505 patients with PAH were identified, 239 (47.3%) of whom have died at follow-up (median 4.85 years, IQR 4.05). The mean age of the patients was 59±16 and 161 (32.7%) were male. Low-volume-low-mass was associated with CMR and right heart catheterisation metrics predictive of improved prognosis. There were 124 patients who underwent follow-up CMR (median 1.11 years, IQR 0.78). At both baseline and follow-up, the high-volume-low-mass group had worse prognosis than the low-volume-low-mass group (p<0.001). With PAH therapy, 73.5% of low-volume-low-mass patients remained in this group, whereas only 17.4% of high-volume-low-mass patients transitioned into low-volume-low-mass. CONCLUSIONS: Right ventricular adaptation assessed using CMR has prognostic value in patients with PAH. Patients with maladaptive remodelling (high-volume-low-mass) are at high risk of treatment failure.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Goh ZM, Balasubramanian N, Alabed S, et al. Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response. Heart. 2022. PMID: 35512982. doi:10.1136/heartjnl-2021-320733

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。